IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Skadden Arps
- Winston & Strawn
- Norton Rose
- Sarraf Gentile
- Burns Charest
- Lewis Brisbois
- Kabat Chapman
- WilmerHale
- Greenberg Traurig
- Tarter Krinsky
- Gustafson Gluek
- Fiddler Gonzalez
- McCune Law
- Kirkland & Ellis
- Patterson Belknap
- Goodwin Procter
- Ahern and Associates
- Tostrud Law Group
- Morgan Lewis
- Manatt Phelps
- Kasowitz Benson
- Spiro Harrison
- Harkins Cunningham
- Larson King
- Axinn Veltrop
- Kaplan Fox
- Reed Smith
- Cozen O'Connor
- Buchanan Ingersoll
- Robbins Geller
- Freshfields
- Pashman Stein
- McDermott Will & Schulte
- Levin Sedran
- Armstrong Teasdale
- Dilworth Paxson
- Cleary Gottlieb
- Blank Rome
- Gross & Belsky
- Hogan Lovells
- Arnold & Porter
- Obermayer Rebmann
- Faegre Drinker
- Sills Cummis
- Lowenstein Sandler
- Zuckerman Spaeder
- Vinson & Elkins
- DLA Piper
- DiCello Levitt
- Tycko & Zavareei
- Freedman Boyd
- Earp Cohn
- Steyer Lowenthal
- Zelle LLP
- Cera LLP
- Garwin Gerstein
- Girard Sharp
- Wilson Sonsini
- Krantz & Berman
- Cole Schotz
- White & Case
- Lockridge Grindal
- Proskauer Rose
- Troutman
- Debevoise & Plimpton
- Linklaters LLP
- Baker Botts
- Grabar Law
- Rosenn Jenkins
- Barrack Rodos
- Fox Rothschild
- Anselmi & Carvelli
- Pogust Goodhead
- Cuneo Gilbert
- Stradley Ronon
- Welsh & Recker
- DeCotiis FitzPatrick
- Berry Law LLC
- NastLaw
- Pendley Baudin
- Zwerling Schachter
- Rule Garza
- Joseph Saveri Law Firm
- Competition Law Partners
- Seeger Weiss
- Barrett Law Group
- McConnell Valdes
- Saiber LLC
- Hausfeld LLP
- Gordon Rees
- Paul Weiss
- Safirstein Law
- Neufeld Scheck
- Spector Roseman
- Edelson Lechtzin
- Goldman Scarlato
- Hach Rose Schirripa
- Faruqi & Faruqi
- Schertler Onorato
- Wiggin & Dana
- Shinder Cantor
- Wexler Boley
- Bailey & Glasser
- Royer Cooper
- Roberts Law Firm US
- Motley Rice
- Shapiro Arato
- Walsh Pizzi
- Stueve Siegel
- Boni Zack
- Segal McCambridge
- Venable LLP
- Lyden Chappell
- Andrus Anderson
- Duane Morris
- Hagens Berman
- Bonsignore Trial Lawyers
- Napoli Shkolnik
- Carella Byrne
- Kelley Drye
- McCracken Stemerman
- Boies Schiller
- Fenwick & West
- Williams & Connolly
- Polsinelli PC
- Kohn Swift
- King & Spalding
- Wisner Baum
- George Feldman
- Bailey Duquette
- Stevens & Lee
- Calcaterra Pollack
- Ballard Spahr
- Foley & Lardner
- Baker & Hostetler
- Francis Mailman
- Rosca Scarlato
- Weil Gotshal
- Gibson Dunn
- O'Melveny & Myers
- Nussbaum Law Group
- Morrison & Foerster
- Haynes Boone
- Schneider Wallace
- Steptoe LLP
- Lieff Cabraser
- Barnes & Thornburg
- Crowell & Moring
- Butler Reichline
- Dugan Law Firm
- Marks O'Neill
- Langer Grogan
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Heins Mills
- Kralowec Law
- Furth Salem
- Hangley Aronchick
- Pullman & Comley
- Yarborough Law Firm
- Bartlit Beck
- Wolf Haldenstein
- Cotchett Pitre
- Lowey Dannenberg
- Steven Williams Law
- Taus Cebulash
- Bingham McCutchen
- Scott&Scott
- White and Williams
- Dechert LLP
- Seward & Kissel
- Hughes Hubbard
- Simpson Thacher & Bartlett LLP
- Miller & Chevalier
- Lite DePalma
- Berman Tabacco
- Radice Law Firm
- Whatley Kallas
- Cohen Milstein
- O’Neill & Borges
- Sperling Kenny
- Clark Hill
- Miller Shah
- Zimmerman Reed
- Berger Montague
- Susman Godfrey
- Glancy Prongay
- K&L Gates
- Alston & Bird
- Constantine Cannon
- Harris St. Laurent
- Shipman & Goodwin
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Haug Partners
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
Companies
- Albertsons Cos. Inc.
- J.M. Smith Corp.
- Walgreens Boots Alliance Inc.
- McKesson Corp.
- Perrigo Co. PLC
- Humana Inc.
- Impax Laboratories, Inc.
- Blue Cross Blue Shield Association
- MSP Recovery
- Endo International PLC
- Bausch Health Cos. Inc.
- Sandoz International GmbH
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Lannett Company, Inc
- Health Care Service Corp.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- The Cigna Group
- Cencora Inc.
- Glenmark Pharmaceuticals Ltd.
- Viatris Inc.
- Walmart Inc.
- Hi-Tech Pharmacal Co., Inc.
- Red Oak Sourcing LLC
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Florida Blue
- Aetna Inc.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- Centene Corp.
- G&W Laboratories Inc.
- The Kroger Co.
- Upsher-Smith Laboratories Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- Novartis AG
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
April 06, 2021
Calif. AG Says Sanctions Rec. 'Misunderstands' Generics MDL
The California Attorney General's Office said a special master went too far in recommending sanctions against it for not living up to discovery obligations in a multidistrict litigation that accuses much of the generic-drug industry of price-fixing, saying Monday all the material is coming from the defendant drugmakers and third parties.
-
March 30, 2021
Generics Cos. Argue For Heritage Bellwether In Antitrust MDL
A group of generic-drug makers facing multiple antitrust complaints for allegedly working in concert to inflate medication prices has urged a Pennsylvania federal judge to choose a case against Heritage Pharmaceuticals as the bellwether.
-
March 23, 2021
Generics MDL Special Master Says Calif. AG Merits Sanctions
A special master on Monday recommended that the California Attorney General's Office be sanctioned for failing to live up to discovery promises in the sprawling multidistrict litigation that accuses much of the generic drug industry of price-fixing, saying the office should be limited to only evidence that was produced on deadline.
-
March 17, 2021
States Push New Bellwether Generic Drug Price-Fixing Case
If a Pennsylvania federal judge wants to swap out the bellwether case in sprawling litigation that accuses much of the generic drug industry of price-fixing, a coalition of attorneys general want her to choose a different state-brought case than the one she's currently considering as a replacement.
-
March 02, 2021
Teva, Mylan Back Plan For New Bellwether In Price-Fix MDL
Mylan, Teva and Par Pharmaceuticals are among a group of generic-drug makers that told a Pennsylvania federal judge Monday they're fine with her plan to swap out a bellwether case in multidistrict litigation that accuses most of the generics industry of price-fixing.
-
February 09, 2021
Teva-Centric Price-Fix Case Likely To Lose Bellwether Status
A Pennsylvania federal judge said Tuesday she was "no longer convinced" that a price-fixing lawsuit centered around Teva from state attorneys general should serve as a bellwether trial for multidistrict litigation accusing most of the generic-drug industry of price-fixing, thanks to related criminal charges against the company.
-
January 03, 2021
Antitrust Conduct Cases To Watch In 2021
U.S. technology companies are facing a mountain of antitrust litigation heading into 2021, as enforcers push blockbuster monopolization cases against Google and Facebook. Meanwhile, long-running criminal probes in the generic drug and poultry industries are heating up. Here’s a look at the biggest antitrust conduct cases to watch.
-
November 23, 2020
Teva's Bid To Duck MDL Trials Slammed As 'Fool's Errand'
A group of drug buyers and states asked a Pennsylvania federal judge Friday to reject Teva Pharmaceutical's bid to scrap a bellwether trial in multidistrict litigation over civil price-fixing claims to await the outcome of related criminal charges, calling the drugmaker's efforts to keep witnesses from overlapping a "fool's errand."
-
September 10, 2020
State AGs Say Drugmakers Want To Delay Price-Fixing Trials
A contingent of state attorneys general suing generic-drug makers over allegations of price-fixing as part of a sprawling multidistrict litigation have said that drugmakers' proposed schedule for four bellwether cases would delay the first trial for months longer than necessary.
-
August 27, 2020
Pa. Avoiding Discovery In Price-Fixing Case, Drugmakers Say
Generic-drug companies accused of orchestrating an industrywide price-fixing scheme have told a Pennsylvania federal court that the state attorney general's office is refusing to hand over documents they need to help mount a defense.